Form 4: IQVIA Executive Eric Sherbet Reports Stock Transactions
SEC Form 4 Filing
Eric Sherbet, an Executive Vice President at IQVIA Holdings Inc., reported the acquisition of shares and stock appreciation rights, as well as the disposal of shares to cover tax obligations.
Summary
- Eric Sherbet, an Executive Vice President at IQVIA Holdings Inc., reported transactions involving the company's stock on January 28, 2025.
- He acquired 2,356 shares of common stock as part of a performance-based restricted stock unit award, with the performance conditions being met on the same day.
- Additionally, he acquired 14,045 stock appreciation rights (SARs) that vest in three annual installments starting January 28, 2026.
- To cover tax obligations, 605 shares were disposed of at a price of $203.43 per share.
- Following these transactions, Mr. Sherbet beneficially owns 21,287 shares of common stock and 14,045 stock appreciation rights.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and performance-based awards, which are generally viewed positively. The tax-related sale is a neutral event.
Positives
- The acquisition of 2,356 shares indicates that performance goals were met, which is a positive sign for the company's performance.
- The grant of 14,045 stock appreciation rights provides an incentive for future performance and aligns the executive's interests with those of the shareholders.
Negatives
- The disposal of 605 shares, while for tax purposes, could be perceived negatively by some investors as a reduction in the executive's direct shareholding.
Risks
- The vesting of the stock appreciation rights is dependent on the executive's continued employment and the company's performance over the next three years.
- Fluctuations in the stock price could impact the value of the stock appreciation rights.
Future Outlook
The stock appreciation rights vest in three annual installments beginning on January 28, 2026, which provides a future incentive for the executive.
Management Comments
- The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It reflects the company's compensation practices and alignment of executive interests with shareholder value.
Comparison to Industry Standards
- Stock-based compensation, including restricted stock units and stock appreciation rights, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to incentivize executives.
- Companies like Oracle, Salesforce, and Medtronic also use similar compensation structures to align executive performance with company goals.
- The vesting schedule of the stock appreciation rights, in three annual installments, is a typical approach to ensure long-term commitment from the executive.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
- The vesting of stock appreciation rights aligns the executive's interests with those of the shareholders.
Next Steps
- The stock appreciation rights will vest in three annual installments starting January 28, 2026.
Key Dates
| Date | Description |
|---|---|
| 02/10/2022 | Date of grant for the performance-based restricted stock units. |
| 01/28/2025 | Date of the stock transactions and the determination that performance conditions were met. |
| 01/28/2026 | Start date for the vesting of the stock appreciation rights in three annual installments. |
| 01/30/2025 | Date of the signature of the Form 4 filing. |
| 01/28/2035 | Expiration date of the stock appreciation rights. |
Keywords
IQVIA, stock appreciation rights, stock transaction, executive compensation, performance-based, restricted stock units, insider trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.